Pro-Dex, Inc. (PDEX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1159379,
    "name": "Pro-Dex, Inc.",
    "stock_name": "Pro-Dex, Inc.",
    "full_name": "Pro-Dex, Inc.",
    "name_url": "stocks-analysis/pro-dex-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "40.70",
    "chg": 3.14,
    "chgp": "8.36%",
    "dir": 1,
    "prev_price": "37.56",
    "mcapval": "116.03",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US74265M2052",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "39.17 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pro-dex-inc-1159379-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Pro-Dex, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pro-dex-inc-overvalued-or-undervalued-3637366",
        "imagepath": "",
        "date": "2025-10-21 12:00:51",
        "description": "As of 17 October 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. Based on the current metrics, the company appears undervalued. Key ratios supporting this assessment include a P/E ratio of 16, an EV to EBITDA of 11.51, and a PEG ratio of 0.18, all of which suggest that the stock is trading at a discount relative to its earnings growth potential.\n\nIn comparison to its peers, Pro-Dex, Inc. has a significantly better valuation profile with a P/E of 14.77, while its nearest competitors, such as Prenetics Global Ltd. and Wrap Technologies, Inc., are classified as risky with negative P/Es. Furthermore, the company's return over the past three years of 31.53% contrasts sharply with the S&P 500's return of 81.19%, highlighting a potential for recovery and growth...."
      },
      {
        "title": "Pro-Dex, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pro-dex-inc-sees-valuation-grade-upgrade-from-attractive-to-very-attractive-3640877",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ProDexInc_valuationdot_3640877.png",
        "date": "2025-10-20 16:46:48",
        "description": "Pro-Dex, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation, showcasing a P/E ratio of 16 and a price-to-book value of 3.97. The company exhibits strong profitability with a ROCE of 26.48% and ROE of 25.14%, distinguishing itself from riskier peers in the industry."
      },
      {
        "title": "Is Pro-Dex, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pro-dex-inc-overvalued-or-undervalued-3631775",
        "imagepath": "",
        "date": "2025-10-19 11:56:22",
        "description": "As of 17 October 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company appears undervalued based on several key metrics, including a P/E ratio of 16, an EV to EBITDA ratio of 11.51, and a PEG ratio of 0.18, which suggests strong growth potential relative to its price. In comparison, its peer Prenetics Global Ltd. has a P/E of -3.15, while Wrap Technologies, Inc. shows a P/E of -6.12, highlighting Pro-Dex's relative strength in valuation.\n\nDespite the positive valuation metrics, Pro-Dex has faced significant stock declines recently, with a year-to-date return of -43.91% compared to a 13.30% return for the S&P 500. This stark contrast underscores the potential mispricing of the stock, reinforcing the notion that it may be undervalued in the current market environment...."
      },
      {
        "title": "Pro-Dex, Inc. Hits 52-Week Low at $24.04 Amid Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pro-dex-inc-hits-52-week-low-at-2404-amid-declining-performance-3622731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ProDexInc_priceRelatedfactors_3622731.png",
        "date": "2025-10-15 16:43:50",
        "description": "Pro-Dex, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting recent struggles despite a strong one-year performance. The company, with a market cap of USD 116 million, faces challenges in maintaining growth and lacks a dividend yield, raising sustainability concerns."
      },
      {
        "title": "Pro-Dex, Inc. Hits 52-Week Low at $24.22 Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pro-dex-inc-hits-52-week-low-at-2422-amid-market-challenges-3620074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ProDexInc_priceRelatedfactors_3620074.png",
        "date": "2025-10-14 18:39:01",
        "description": "Pro-Dex, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, contrasting with its previous high. Despite this, the company has outperformed the S&P 500 over the past year and maintains a solid return on equity and low debt-to-equity ratio, though it lacks a dividend yield."
      },
      {
        "title": "Is Pro-Dex, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pro-dex-inc-technically-bullish-or-bearish-3545140",
        "imagepath": "",
        "date": "2025-09-20 19:04:35",
        "description": "As of 5 September 2025, the technical trend for Pro-Dex, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe and a bearish signal from the daily moving averages. The weekly RSI remains bullish, but the overall indicators, including the KST and Dow Theory, suggest a bearish sentiment. Additionally, the stock has underperformed the S&P 500 over the past month and year-to-date, with returns of -21.18% and -25.65% respectively, compared to the S&P's 2.33% and 12.22%...."
      },
      {
        "title": "Is Pro-Dex, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pro-dex-inc-overvalued-or-undervalued-3541863",
        "imagepath": "",
        "date": "2025-09-20 17:38:15",
        "description": "As of 30 June 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 16, a PEG ratio of 0.18, and an EV to EBITDA ratio of 11.51, which are favorable compared to its peers. For instance, Pro-Dex's P/E ratio is significantly better than Prenetics Global Ltd., which has a P/E of -3.15, and Wrap Technologies, Inc., with a P/E of -6.12.\n\nDespite recent struggles, with a year-to-date return of -25.65% compared to the S&P 500's 12.22%, Pro-Dex has shown resilience with a one-year return of 36.31%, outperforming the S&P 500's 17.14%. This performance, combined with strong financial metrics, reinforces the view that Pro-Dex is undervalued in the current market...."
      }
    ],
    "total": 12,
    "sid": "1159379",
    "stock_news_url": "https://www.marketsmojo.com/news/pro-dex-inc-1159379"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Pro-Dex, Inc. overvalued or undervalued?

2025-10-21 12:00:51

As of 17 October 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. Based on the current metrics, the company appears undervalued. Key ratios supporting this assessment include a P/E ratio of 16, an EV to EBITDA of 11.51, and a PEG ratio of 0.18, all of which suggest that the stock is trading at a discount relative to its earnings growth potential. In comparison to its peers, Pro-Dex, Inc. has a significantly better valuation profile with a P/E of 14.77, while its nearest competitors, such as Prenetics Global Ltd. and Wrap Technologies, Inc., are classified as risky with negative P/Es. Furthermore, the company's return over the past three years of 31.53% contrasts sharply with the S&P 500's return of 81.19%, highlighting a potential for recovery and growth....

Pro-Dex, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics

2025-10-20 16:46:48

Pro-Dex, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation, showcasing a P/E ratio of 16 and a price-to-book value of 3.97. The company exhibits strong profitability with a ROCE of 26.48% and ROE of 25.14%, distinguishing itself from riskier peers in the industry.

Is Pro-Dex, Inc. overvalued or undervalued?

2025-10-19 11:56:22

As of 17 October 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company appears undervalued based on several key metrics, including a P/E ratio of 16, an EV to EBITDA ratio of 11.51, and a PEG ratio of 0.18, which suggests strong growth potential relative to its price. In comparison, its peer Prenetics Global Ltd. has a P/E of -3.15, while Wrap Technologies, Inc. shows a P/E of -6.12, highlighting Pro-Dex's relative strength in valuation. Despite the positive valuation metrics, Pro-Dex has faced significant stock declines recently, with a year-to-date return of -43.91% compared to a 13.30% return for the S&P 500. This stark contrast underscores the potential mispricing of the stock, reinforcing the notion that it may be undervalued in the current market environment....

Pro-Dex, Inc. Hits 52-Week Low at $24.04 Amid Declining Performance

2025-10-15 16:43:50

Pro-Dex, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting recent struggles despite a strong one-year performance. The company, with a market cap of USD 116 million, faces challenges in maintaining growth and lacks a dividend yield, raising sustainability concerns.

Pro-Dex, Inc. Hits 52-Week Low at $24.22 Amid Market Challenges

2025-10-14 18:39:01

Pro-Dex, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, contrasting with its previous high. Despite this, the company has outperformed the S&P 500 over the past year and maintains a solid return on equity and low debt-to-equity ratio, though it lacks a dividend yield.

Is Pro-Dex, Inc. technically bullish or bearish?

2025-09-20 19:04:35

As of 5 September 2025, the technical trend for Pro-Dex, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe and a bearish signal from the daily moving averages. The weekly RSI remains bullish, but the overall indicators, including the KST and Dow Theory, suggest a bearish sentiment. Additionally, the stock has underperformed the S&P 500 over the past month and year-to-date, with returns of -21.18% and -25.65% respectively, compared to the S&P's 2.33% and 12.22%....

Is Pro-Dex, Inc. overvalued or undervalued?

2025-09-20 17:38:15

As of 30 June 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 16, a PEG ratio of 0.18, and an EV to EBITDA ratio of 11.51, which are favorable compared to its peers. For instance, Pro-Dex's P/E ratio is significantly better than Prenetics Global Ltd., which has a P/E of -3.15, and Wrap Technologies, Inc., with a P/E of -6.12. Despite recent struggles, with a year-to-date return of -25.65% compared to the S&P 500's 12.22%, Pro-Dex has shown resilience with a one-year return of 36.31%, outperforming the S&P 500's 17.14%. This performance, combined with strong financial metrics, reinforces the view that Pro-Dex is undervalued in the current market....

View All News